![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1594, 2007-01, pp. : 21-21
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
EMEA recommends restrictions for piroxicam use
Reactions Weekly, Vol. 1, Iss. 1158, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
EMEA recommends restricting use of moxifloxacin, norfloxacin
Inpharma, Vol. 1, Iss. 1649, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
EMEA recommends safe use of methylphenidate in children
Reactions Weekly, Vol. 1, Iss. 1237, 2009-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
EMA recommends restrictions on Multaq use
Reactions Weekly, Vol. 1, Iss. 1371, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
EMEA recommends veralipride withdrawal
Reactions Weekly, Vol. 1, Iss. 1162, 2007-01 ,pp. :